BamSEC and AlphaSense Join Forces
Learn More

Esperion Therapeutics Inc. – Indentures

NASDAQ: ESPR    
Share price (6/2/26): $3.14    
Market cap (6/2/26): $808 million

Indentures Filter

EX-4.5
from S-3 39 pages Esperion Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 202[·] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 39 pages Esperion Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 120 pages Esperion Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as Trustee Indenture Dated as of December 17, 2024 5.75% Convertible Senior Subordinated Notes Due 2030
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.2
from 8-K 17 pages Pre-Funded Common Stock Purchase Warrant Esperion Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Common Stock Purchase Warrant Esperion Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Esperion Therapeutics, Inc
12/34/56
EX-4.4
from S-3ASR 37 pages Esperion Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 37 pages Esperion Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 35 pages Esperion Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.3
from S-3ASR 35 pages Esperion Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 128 pages Esperion Therapeutics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of November 16, 2020 4.00% Convertible Senior Subordinated Notes Due 2025
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.2
from S-3 70 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 65 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.2
from S-3 82 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 66 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.1
from 8-K 11 pages Warrant to Purchase Stock
12/34/56
EX-4.2
from S-3 67 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 65 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56